" class="no-js "lang="en-US"> Immunovia Archives - Medtech Alert
Saturday, March 25, 2023

Sort by:


Top Post

Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs

Immunovia, the diagnostics company that has launched the world’s first blood test dedicated to the […]

The PanDIA-1 Study, for Early Detection of Pancreatic Cancer in Newly Onset Type 2 Diabetics, Moves Into Next Phase

Immunovia today announced the PanDIA-1 study for the early detection of pancreatic cancer in newly […]

Immunovia Appoints Jeff Borcherding, Previously Chief Marketing Officer at Myriad Genetics, to Lead Immunovia's US Business

Immunovia (Nasdaq Stockholm: IMMNOV) has appointed Jeff Borcherding as CEO of its US subsidiary Immunovia, Inc. He […]

Immunovia Further Strengthens IP Portfolio for its IMMray ™ PanCan-d Signature

Immunovia AB (publ) announced today that the United States Patent and Trademark Office (USPTO) has […]

  1. Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
  2. Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
  3. Companion Spine Closes $60.1 Million Series A Funding Round Read more
  4. EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
  5. Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more